MaxCyte, Inc.
MXCT · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $436,172 | $485,362 | $555,297 | $923,408 |
| - Cash | $27,884 | $46,506 | $11,065 | $47,782 |
| + Debt | $18,034 | $18,743 | $16,095 | $5,682 |
| Enterprise Value | $426,322 | $457,599 | $560,327 | $881,308 |
| Revenue | $38,627 | $41,288 | $44,261 | $33,894 |
| % Growth | -6.4% | -6.7% | 30.6% | – |
| Gross Profit | $31,527 | $36,546 | $39,163 | $30,247 |
| % Margin | 81.6% | 88.5% | 88.5% | 89.2% |
| EBITDA | -$46,407 | -$44,128 | -$24,663 | -$16,614 |
| % Margin | -120.1% | -106.9% | -55.7% | -49% |
| Net Income | -$41,055 | -$37,923 | -$23,571 | -$19,082 |
| % Margin | -106.3% | -91.8% | -53.3% | -56.3% |
| EPS Diluted | -0.39 | -0.37 | -0.19 | -0.22 |
| % Growth | -5.4% | -94.7% | 13.6% | – |
| Operating Cash Flow | -$27,610 | -$21,686 | -$14,783 | -$10,680 |
| Capital Expenditures | -$1,651 | -$3,700 | -$18,477 | -$3,834 |
| Free Cash Flow | -$29,261 | -$25,386 | -$33,260 | -$14,514 |